Science and Innovation Minister Paul Goldsmith has announced the appointment of Dr Andrew McLeod to the Science Board for a term of three years
The Science Board is responsible for investing funding used predominantly by research organisations for science, technology, research, and related activities.
Dr McLeod studied Pharmacy at Otago University before completing his PhD and post-doctoral studies in Pharmaceutical Chemistry at the University of California in San Francisco. He has held senior management positions at Douglas Pharmaceuticals, Dow Pharmaceutical Sciences and Douglas Nutrition Ltd.
Currently, Dr McLeod is leading the medical division of Douglas Pharmaceuticals Global Dermatology Franchise in New Zealand.
“More information on the Science Board can be found on the Ministry of Business, Innovation and Employment’s website.